Cui-Ling Shu

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
FK506 is an efficient immunosuppressive agent with an increasing number of clinical applications. It has been approved to prevent rejection in transplant patients and be efficacious in several autoimmune diseases. Its immunosuppressive activity results from binding to receptor proteins designated as immunophilins (i.e., FKBP12, FK506 binding protein).(More)
  • 1